The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 73, Issue 8, 2014, Pages 1537-1540

  Risselada, Anna P ^a   Kruize, Aike A ^a   Goldschmeding, Roel ^a   Lafeber, Floris P J G ^a   Bijlsma, Johannes W J ^a   Van Roon, Joel A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PLASMA CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX; SALIVARY GLAND; SJOEGREN SYNDROME;

DISEASE ACTIVITY; OUTCOMES RESEARCH; SJØGREN'S SYNDROME;

ADULT; AGED; BIOPSY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PLASMA CELLS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SALIVARY GLANDS, MINOR; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME;

EID: 84903881565     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204634     Document Type: Article

References (14)

1. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8. (Pubitemid 34539104)
2. Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64:475-87.
3. Theander E, Vasaitis L, Baecklund E, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis 2011;70:1363-8.
4. Risselada AP, Looije MF, Kruize AA, et al. The role of ectopic germinal centers in the immunopathology of Primary Sjögren's syndrome: a systematic review. Semin Arthritis Rheum 2012;42:368-76.
5. Fox RI. The importance of minor salivary gland biopsy in prediction of lymphoma in Sjögren's syndrome: should we be obtaining more information about prognosis from minor salivary gland samples? Ann Rheum Dis 2011;70:1351-3.
6. Bodeutsch C, de Wilde PCM, Kater L, et al. Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjögren's syndrome. Arthritis Rheum 1992;35:1075-87.
7. Speight PM, Cruchley A, Williams DM. Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjögren's syndrome. J Oral Pathol Med 1990;19:126-30. (Pubitemid 20178563)
8. Van Woerkom JM, Kruize AA, Barendregt PJ, et al. Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjögren's syndrome. Rheumatology 2006;45:470-7.
9. Salomonsson S, Rozell BL, Heimburger M, et al. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome. J Oral PatholMed 2009;38:282-8.
10. Risselada AP, Kruize AA, Bijlsma JWJ. Clinical applicability of the EULAR Sjögren's Syndrome disease activity index (ESSDAI) - a cumulative ESSDAI score adds in describing disease severity. Ann Rheum Dis 2012;71:631.
11. Risselada AP, Kruize AA, Bijlsma JWJ. Clinical features distinguishing lymphoma development in primary Sjögren's syndrome - a retrospective cohort study. Semin Arthritis Rheum 2013;43:171-7.
12. Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010;69:1103-9.
13. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968;21:656-60.
14. Fox PC, Datiles M, Atkinson JC, et al. Prednisone and peroxicam for treatment of primary Sjögren's syndrome. Clin Exp Rheumatol 1993;11:149-56. (Pubitemid 23155983)